Trending/morphologic
Drug Induces Morphologic, Molecular and Clinical Remissions in Myelofibrosis
Imetelstat, a novel telomerase inhibiting drug, has been found to induce morphologic, molecular and clinical remissions in some patients with myelofibrosis. Hematologist and lead author…
No information found.
Special Topics
Sign up
Social Media Network
A network for digital healthcare communicators
Mayo Clinic Connect
An online patient support community